These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21169382)
1. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs. Blume M; Hliscs M; Rodriguez-Contreras D; Sanchez M; Landfear S; Lucius R; Matuschewski K; Gupta N FASEB J; 2011 Apr; 25(4):1218-29. PubMed ID: 21169382 [TBL] [Abstract][Full Text] [Related]
2. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes. Woodrow CJ; Burchmore RJ; Krishna S Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735 [TBL] [Abstract][Full Text] [Related]
3. Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum. Jiang X; Yuan Y; Huang J; Zhang S; Luo S; Wang N; Pu D; Zhao N; Tang Q; Hirata K; Yang X; Jiao Y; Sakata-Kato T; Wu JW; Yan C; Kato N; Yin H; Yan N Cell; 2020 Oct; 183(1):258-268.e12. PubMed ID: 32860739 [TBL] [Abstract][Full Text] [Related]
4. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds. Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322 [TBL] [Abstract][Full Text] [Related]
5. Why is the Plasmodium falciparum hexose transporter a promising new drug target? Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822 [TBL] [Abstract][Full Text] [Related]
6. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality. Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450 [TBL] [Abstract][Full Text] [Related]
7. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Joet T; Eckstein-Ludwig U; Morin C; Krishna S Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024 [TBL] [Abstract][Full Text] [Related]
8. Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents. Huang J; Yuan Y; Zhao N; Pu D; Tang Q; Zhang S; Luo S; Yang X; Wang N; Xiao Y; Zhang T; Liu Z; Sakata-Kato T; Jiang X; Kato N; Yan N; Yin H Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33402433 [TBL] [Abstract][Full Text] [Related]
9. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. Woodrow CJ; Penny JI; Krishna S J Biol Chem; 1999 Mar; 274(11):7272-7. PubMed ID: 10066789 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of Won JY; Mazigo E; Cha SH; Han JH Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613 [No Abstract] [Full Text] [Related]
11. Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle. Slavic K; Delves MJ; Prudêncio M; Talman AM; Straschil U; Derbyshire ET; Xu Z; Sinden RE; Mota MM; Morin C; Tewari R; Krishna S; Staines HM Antimicrob Agents Chemother; 2011 Jun; 55(6):2824-30. PubMed ID: 21402842 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model. Manning SK; Woodrow C; Zuniga FA; Iserovich P; Fischbarg J; Louw AI; Krishna S J Biol Chem; 2002 Aug; 277(34):30942-9. PubMed ID: 12042321 [TBL] [Abstract][Full Text] [Related]
13. Transport proteins of Plasmodium falciparum: defining the limits of metabolism. Krishna S; Webb R; Woodrow C Int J Parasitol; 2001 Oct; 31(12):1331-42. PubMed ID: 11566301 [TBL] [Abstract][Full Text] [Related]
14. Expression of parasite transporters in Xenopus oocytes. Krishna S; Woodrow CJ Novartis Found Symp; 1999; 226():126-39; discussion 139-44. PubMed ID: 10645543 [TBL] [Abstract][Full Text] [Related]
15. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development. Deniskin R; Frame IJ; Sosa Y; Akabas MH Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473 [TBL] [Abstract][Full Text] [Related]
16. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir. Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369 [TBL] [Abstract][Full Text] [Related]
17. Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors. Owoloye AJ; Ligali FC; Enejoh OA; Musa AZ; Aina O; Idowu ET; Oyebola KM PLoS One; 2022; 17(8):e0268269. PubMed ID: 36026508 [TBL] [Abstract][Full Text] [Related]
18. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family. Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947 [TBL] [Abstract][Full Text] [Related]
19. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering. Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153 [TBL] [Abstract][Full Text] [Related]
20. The molecular basis for sugar import in malaria parasites. Qureshi AA; Suades A; Matsuoka R; Brock J; McComas SE; Nji E; Orellana L; Claesson M; Delemotte L; Drew D Nature; 2020 Feb; 578(7794):321-325. PubMed ID: 31996846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]